Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abvc Biopharma (ABVC) Minority Interest (2018 - 2025)

Historic Minority Interest for Abvc Biopharma (ABVC) over the last 8 years, with Q3 2025 value amounting to $2.4 million.

  • Abvc Biopharma's Minority Interest rose 89816.18% to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 million, marking a year-over-year increase of 89816.18%. This contributed to the annual value of -$502181.0 for FY2024, which is 6703.9% down from last year.
  • Per Abvc Biopharma's latest filing, its Minority Interest stood at $2.4 million for Q3 2025, which was up 89816.18% from $2.5 million recorded in Q2 2025.
  • Abvc Biopharma's Minority Interest's 5-year high stood at $2.6 million during Q1 2025, with a 5-year trough of -$1.0 million in Q3 2021.
  • For the 5-year period, Abvc Biopharma's Minority Interest averaged around $150192.7, with its median value being -$153822.0 (2022).
  • As far as peak fluctuations go, Abvc Biopharma's Minority Interest tumbled by 210046.32% in 2024, and later surged by 115852.76% in 2025.
  • Quarter analysis of 5 years shows Abvc Biopharma's Minority Interest stood at $26689.0 in 2021, then soared by 415.4% to $137554.0 in 2022, then tumbled by 318.56% to -$300637.0 in 2023, then crashed by 67.04% to -$502181.0 in 2024, then soared by 584.9% to $2.4 million in 2025.
  • Its Minority Interest stands at $2.4 million for Q3 2025, versus $2.5 million for Q2 2025 and $2.6 million for Q1 2025.